Covid vaccine maker BioNTech reports £972m profit in first quarter

A member of staff uses a needle and a phial of Pfizer/BioNTech Covid-19 vaccine (Justin Tallis/PA)

German pharmaceutical company BioNTech has reported a net profit of 1.13 billion euros (£972 million) in the first quarter of this year on the back of strong revenues from its coronavirus vaccine.

The company’s estimated revenues surged to more than two billion euros for the period from January to March, compared with just 28 million euros in the same period last year.